Results 221 to 230 of about 48,847 (353)
Reduces cardiac remodelling and apoptosis in dogs with MMVD stage B2: Long‐term treatment with ivabradine in dogs with asymptomatic myxomatous mitral valve disease (MMVD) stage B2 reduced heart rate without impairing cardiac function. ABSTRACT Background Ivabradine, a specific funny channel blocker, has shown cardiovascular benefits in humans and ...
Prapawadee Pirintr +6 more
wiley +1 more source
Anti-mitochondrial M2 antibody links to cardiac involvement and immune-mediated inflammatory myopathy-like pathology in myositis. [PDF]
Pang Y +19 more
europepmc +1 more source
ABSTRACT Background Ephedrine, phenylephrine, and norepinephrine are commonly used to manage hypotension during the induction of anaesthesia. The objective of this study was to evaluate whether prophylactic administration of assumed equipotent doses of these vasopressors could maintain systolic arterial blood pressure (SAP) and heart rate (HR) within ...
Gunnar Helge Sjøen +4 more
wiley +1 more source
Impact of digoxin on sinus rhythm restoration after catheter ablation of persistent atrial fibrillation and drug-refractory atrial tachyarrhythmia recurrence: A cohort study. [PDF]
Lin YS +4 more
europepmc +1 more source
Chronic low‐concentration lead exposure accelerates the development of ARHL. Lead exposure mediates damage to cochlear sensory cells via the mitochondrial protease LONP1, leading to irreversible hearing loss. ABSTRACT Heavy metal ion exposure has become a global public health concern.
Xue Bai +10 more
wiley +1 more source
Arrhythmias in Rheumatoid Arthritis: A Call for a Multidisciplinary Team. [PDF]
Ungurean V +14 more
europepmc +1 more source
[Anti-arrhythmia agents and sudden death].
openaire +1 more source
The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes. [PDF]
Firneburg R +9 more
europepmc +1 more source
ABSTRACT Hypertension is a major contributor to cardiovascular diseases, being the most common comorbidity and the biggest risk factor in heart failure with preserved ejection fraction. Angiotensin II (Ang II) is a known hypertension and heart failure inducer in mice, but its role in the causality in phenotype development remains unclear.
Diana Törmä +5 more
wiley +1 more source
Complex interrelationship and therapeutic advances in diabetic patients with atrial fibrillation. [PDF]
Karanikola AE +8 more
europepmc +1 more source

